Neostigmine methylsulfate

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 71839-105
  • Package NDC 71839-105-10
  • Package NDC 71839-105-24
  • Application number ANDA212512
  • SPL ID a90a9fa9-dc93-4e87-94fa-e578918ccfce
  • SPL set ID 971713db-d5ac-44c1-ada5-a56a943d79bf
  • UNII 98IMH7M386
  • RxCUI 311935
  • RxCUI 311936

What the source publishes

Labeler
BE Pharmaceuticals Inc.
Active ingredients
Neostigmine methylsulfate
Form
INJECTION
Routes
INTRAVENOUS
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:71839-105_a90a9fa9-dc93-4e87-94fa-e578918ccfce
{
  "name": "Neostigmine methylsulfate",
  "splId": "a90a9fa9-dc93-4e87-94fa-e578918ccfce",
  "labels": [
    {
      "setId": "971713db-d5ac-44c1-ada5-a56a943d79bf",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=971713db-d5ac-44c1-ada5-a56a943d79bf",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=971713db-d5ac-44c1-ada5-a56a943d79bf"
    }
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "labeler": "BE Pharmaceuticals Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "10 VIAL, MULTI-DOSE in 1 CARTON (71839-105-10)  / 10 mL in 1 VIAL, MULTI-DOSE",
      "package_ndc": "71839-105-10",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20220317"
    },
    {
      "sample": false,
      "description": "24 CARTON in 1 CARTON (71839-105-24)  / 1 VIAL, MULTI-DOSE in 1 CARTON (71839-105-01)  / 10 mL in 1 VIAL, MULTI-DOSE",
      "package_ndc": "71839-105-24",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20190513"
    }
  ],
  "productId": "71839-105_a90a9fa9-dc93-4e87-94fa-e578918ccfce",
  "useDomain": "unknown",
  "dosageForm": "INJECTION",
  "productNdc": "71839-105",
  "deaSchedule": null,
  "genericName": "Neostigmine methylsulfate",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "NEOSTIGMINE METHYLSULFATE",
      "strength": ".5 mg/mL"
    }
  ],
  "applicationNumber": "ANDA212512",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20190513",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "upc": [
      "0371839106011",
      "0371839105014"
    ],
    "unii": [
      "98IMH7M386"
    ],
    "rxcui": [
      "311935",
      "311936"
    ],
    "spl_set_id": [
      "971713db-d5ac-44c1-ada5-a56a943d79bf"
    ],
    "manufacturer_name": [
      "BE Pharmaceuticals Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20261231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:71839-105_a90a9fa9-dc93-4e87-94fa-e578918ccfce"